ArticleActive
Response to Comments: Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)
A59195
Effective: September 1, 2022
Updated: December 31, 2025
Policy Summary
This document (A59195) is a response-to-comments summary related to Proposed LCD DL38227 for Gastrointestinal Pathogen Panels using multiplex NAATs and does not contain explicit coverage criteria in the provided excerpt. To determine indications, limitations, documentation requirements, and frequency limits for coverage, review the final Local Coverage Determination DL38227. The extraction above reflects that the excerpt lacks actionable policy criteria and requires manual review of DL38227 for definitive rules.
Coverage Criteria Preview
Key requirements from the full policy
"This document is a response-to-comments for Proposed LCD DL38227 Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex NAATs and does not itself state coverage criteria; review the final LCD D..."
Sign up to see full coverage criteria, indications, and limitations.